CGEN: Compugen Ltd Company Profile & Statistics

About

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.

Info & Links

CEO

Anat Cohen-Dayag

Headquarters

Azrieli Center, 26 Harokmim Street, Building D
Holon, L3 5885849, ISRAEL

Auditor

KOST FORER GABBAY & KASIERER

Share holders

Employees

Compugen Ltd Statistics

Valuation Measures

Market Capitalization²

133.86M

Enterprise Value

126.64M

Enterprise Value/EBITDA(ttm)

-8.80

Price to Earnings Ratio(ttm)

80.50

Price to Sales(ttm)

2.40

Price to Book(mrq)

2.38

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

38.96%

Operating Margin(ttm)

2.67%

Profit Margin(ttm)

-6.06%

Return on Equity(ttm)

2.62%

Return on Invested Capital(ttm)

13.29%

Return on Assets(ttm)

1.36%

Income Statement

Revenue(ttm)

26.39M

Revenue Per Share(ttm)

Gross Profit(ttm)

19.14M

EBITDA(ttm)³

-14.39M

Net Income Available to Common(ttm)

1.60M

Diluted EPS(ttm)

0.02

Share Statistics

Beta (5Y Monthly)

2.59

52-Week Change

91.96%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

80.76M

% Held by Insiders

9.50%

% Held by Institutions

12.22%

Balance Sheet

Total Cash(mrq)

112.71M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.14%

Quick Ratio(mrq)

4.14%

Book Value Per Share(mrq)

Cash Flow

Operating Cash Flow Per Share(ytd)

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CGEN

Compugen Ltd

Compugen Ltd Profile